EBF 14th Open Symposium

Themes for the 14^th Open Symposium

Our agenda is very ambitious and sets the stage for the new era. You can submit an abstract for podium presentations/workshop with focus on below categories (including suggested sub-themes):

• NCEs (chromatography focus): focus on scientific and regulatory challenges and best state of the art practices for
  • metabolite quantification
  • non-liquid matrix analysis
  • new tools surrounding Chromatography: Blue Sky – new technologies at our doorstep

• NBE (LBA/CBA based): focus on scientific and regulatory challenges and best state of the art practices for
  • critical reagents,
  • immunocapture-LC/MS (hybrid) assays
  • PK interpretation of NBEs (total/Free..)
  • Bio-metabolism of Biotherapeutics

• C&GT and new modalities: are we ready to support the next generation Pharma R&D challenges?
• Immunogenicity: focus on what’s new/different and making sense for biologics, C&GT, new modalities and peptides
• Biomarker Science: includes a spotlight on non-liquid matrices analysis for Biomarkers
• Biosimilars: scientific and regulatory challenges for the BioA community
• Regulations: risk based approach, GCP, data integrity, post Covid-19 inspection readiness (remote inspections), ICH M10 and new emerging guidelines as required
• The Future of Bioanalysis: focus on the role of BioA
  • in speeding up drug development (process, tools, Risk based Approach),
  • for standard of care drugs
  • sustainability – see also:  https://www.future-science.com/doi/10.4155/bio-2021-0017
  • technologies on the fringe – SMART lab and AI

• The Patient: focus on role of BA in patient centric technologies, diagnostics and TDM
• Technology (Chromatography & LBA/CBA):
  • focus on automation/robotics after Covid-19,
  • new tools for increasing throughput, sensitivity and DI compliance (e-environment) for (LC-)MS and LBA/CBA